2026 AMCP annual meeting underway in Nashville | AMCP Annual 2026

The 2026 annual meeting of the Academy of Managed Care Pharmacy (AMCP) is underway in Nashville, Tennessee.

Approximately 4,000 managed care pharmacists and other healthcare professionals are attending the meeting, which is being held at the Music City Center, the city’s convention center.

A talk this morning by Jon Meacham, the presidential historian and award-winning book writer, kicked off the meeting this morning. The meeting is scheduled to end on Thursday morning.

Like nearly everyone in healthcare, pharmacists who work in managed care are grappling with artificial intelligence (AI) and how it will change their jobs, their field and healthcare overall. Yesterday afternoon, AMCP organized a premeeting session titled “The Role of AI in Revolutionizing Managed Care Pharmacy” that featured 14 speakers and four moderators.

Although networking and making professional and social connections is the lifeblood of the AMCP gathering, the meeting features flights of well-attended education sessions, most of which have two or more panelists and a moderator. The topics being covered in today’s education sessions range from HIV pre-exposure prophylaxis to federal healthcare regulations to Humira (adalimumab).

The sessions tomorrow get started with an overview of the pharmaceutical trends and the market forces by Scott Biggs, director in the supplier services group at IQVIA.

Meacham is a contributing editor at TIME and writes “The Long View” column for the The New York Times Book Review. He served as Newsweek's managing editor from 1998 to 2006 and as editor from 2006 to 2010. He won the Pulitzer Prize for biography in 2009 for “American Lion: Andrew Jackson in the White House.”

In addition to education sessions, the AMCP Annual Meeting features the presentation of original in posters along with their abstracts that published simultaneously in the AMCP’s peer-reviewed journal, the Journal of Managed Care Pharmacy and Specialty Pharmacy. Reviewers for the journal rate the abstracts on a 1-5 scale on relevance, originality, quality, bias and clarity. The top ranked abstracts are designated as platinum, gold and silver medal winners.

The platinum medal winners for this meeting included research on the out-of-pocket cost burden for prescription drugs in commercial insurance design; a comparison of glucagon-like peptide drugs to sodium-glucose cotransporter 2 inhibitors on preventing kidney function deterioration among patients with Type 2 diabetes and chronic kidney disease; and the development of an informatics clinical toolkit to identify characteristics of patients eligible for advanced therapies in inflammatory bowel disease.